PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Doctors warn against off-label use of new Alzheimer's drug for cerebral amyloid angiopathy

There is no clinical evidence that the monoclonal antibody aducanumab is beneficial to patients with cerebral amyloid angiopathy, according to officers with the International Cerebral Amyloid Angiography Association.

2021-07-06
(Press-News.org) BOSTON - A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA). In a letter published in The Lancet Neurology, Greenberg and eight other officers of the association wrote that there is no clinical evidence that the monoclonal antibody aducanumab is beneficial to patients with CAA, a condition in which proteins known as amyloid corrode arterial walls in the brain and can lead to bleeding and stroke.

"We believe that there are substantial uncertainties and concerns about both the safety and efficacy of aducanumab in patients diagnosed with CAA [and] therefore believe [it] should not be used for the purpose of treating CAA outside the context of a research trial," the letter stated.

The FDA approved aducanumab on June 7 under the FDA's accelerated approval process for drugs that treat serious conditions and fill an unmet medical need. While the approval was specifically for Alzheimer's disease, it opens the door for physicians to legally prescribe aducanumab off-label for cerebral amyloid angiopathy. Indeed, CAA is thought to be triggered, as in Alzheimer's, by a harmful accumulation of amyloid beta deposits in the brain. Unlike Alzheimer's, however, those deposits typically gather in the cerebral blood vessels, not the brain tissue itself. In giving the green light to aducanumab, the FDA took a position contrary to its own independent advisory committee, as well as many scientists and physicians, who contend there is no convincing evidence to show the drug helps patients.

Leading authorities in the field of cerebral amyloid angiopathy have now taken their own stand, recommending that aducanumab not be prescribed off-label for treatment of CAA. From an efficacy standpoint, the ICAAA officers noted that amyloid beta deposits in blood vessels of the brain appear to be more resistant to antibody-mediated treatment than plaque deposits in the brain tissue, and that insufficient evidence existed to suggest aducanumab was capable of clearing those blood vessels. The physicians cited a previous clinical trial of another anti-amyloid antibody, ponezumab, which found that blood vessel function in patients with CAA trended toward worsening rather than improving following three monthly infusions of the agent.

In terms of safety, the letter from Greenberg and his colleagues cited the fact that amyloid-related imaging abnormalities (ARIAs) had emerged as major adverse events in patients enrolled in trials of aducanumab and other anti-amyloid antibody drugs. ARIAs, which manifest as bleeding or swelling in the brain and are detectable through MRI imaging, are postulated to be triggered by CAA. What the physicians found worrisome was that these abnormalities might occur even more frequently in patients being treated for CAA than the high rates observed in patients treated for Alzheimer's disease.

While discouraging off-label use of aducanumab, Greenberg drew a distinction between patients diagnosed with cerebral amyloid angiopathy and those diagnosed with Alzheimer's disease. "We haven't taken a position on whether an Alzheimer's patient who also has markers of CAA should be prescribed aducanumab," he says. "What we are saying is that the drug shouldn't be prescribed for the purpose of treating CAA."

INFORMATION:

Greenberg is a professor of Neurology at Harvard Medical School and an internationally recognized authority on the diagnosis, causes and treatment of cerebral amyloid angiopathy.

About the Massachusetts General Hospital Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America's Best Hospitals."



ELSE PRESS RELEASES FROM THIS DATE:

Relationship between chromosomal instability and senescence revealed in the fly Drosophila

Relationship between chromosomal instability and senescence revealed in the fly Drosophila
2021-07-06
Chromosomal instability is a feature of solid tumours such as carcinoma. Likewise, cellular senescence is a process that is highly related to cellular ageing and its link to cancer is becoming increasingly clear. Scientists led by ICREA researcher Dr. Marco Milán at IRB Barcelona have revealed the link between chromosomal instability and cellular senescence. "Chromosomal instability and senescence are two characteristics common to most tumours, and yet it was not known how one related to the other. Our studies indicate that senescence may be one of the intermediate links between chromosomal alterations and cancer," says Dr. Milan, head of the Development and Growth Control laboratory at IRB Barcelona. "The behaviour we saw in cells with chromosomal instability ...

Digital pens provide new insight into cognitive testing results

2021-07-06
(Boston)--During neuropsychological assessments, participants complete tasks designed to study memory and thinking. Based on their performance, the participants receive a score that researchers use to evaluate how well specific domains of their cognition are functioning. Consider, though, two participants who achieve the same score on one of these paper-and-pencil neuropsychological tests. One took 60 seconds to complete the task and was writing the entire time; the other spent three minutes, and alternated between writing answers and staring off into space. If researchers ...

Study reveals source of remarkable memory of "superagers"

2021-07-06
BOSTON -- As we age, our brains typically undergo a slow process of atrophy, causing less robust communication between various brain regions, which leads to declining memory and other cognitive functions. But a rare group of older individuals called "superagers" have been shown to learn and recall novel information as well as a 25-year-old. Investigators from Massachusetts General Hospital (MGH) have now identified the brain activity that underlies superagers' superior memory. "This is the first time we have images of the function of superagers' brains as they actively learn and remember new information," says Alexandra Touroutoglou, PhD, director of Imaging ...

Developing new techniques to build biomaterials

Developing new techniques to build biomaterials
2021-07-06
Scientists at the University of Leeds have developed an approach that could help in the design of a new generation of synthetic biomaterials made from proteins. The biomaterials could eventually have applications in joint repair or wound healing as well as other fields of healthcare and food production.   But one of the fundamental challenges is to control and fine tune the way protein building blocks assemble into complex protein networks that form the basis of biomaterials.   Scientists at Leeds are investigating how changes to the structure and mechanics of individual protein building blocks - changes at the nanoscale - can alter the structure and mechanics of the biomaterial ...

Studies add to concern about climate tipping

Studies add to concern about climate tipping
2021-07-06
Two model studies document the probability of climate tipping in Earth subsystems. The findings support the urgency of restricting CO2 emissions as abrupt climate changes might be less predictable and more widespread in the climate system than anticipated. The work is part of the European TiPES project, coordinated by the University of Copenhagen, Denmark but was conducted by Professor Michael Ghil, Ecole Normale Supérieure, Paris, France and coauthours from The Royal Meteorological Institute of Belgium and Parthenope University of Naples, Italy. Tipping could be imminent It is often assumed climate change will proceed gradually as we increase the amounts of CO2 in ...

Asymptomatic adults may be reservoirs of Streptococcus pneumoniae

Asymptomatic adults may be reservoirs of Streptococcus pneumoniae
2021-07-06
Streptococcus pneumoniae is a major human pathogen and a leading cause of several infectious diseases including pneumonia, the third-leading cause of death in Portugal. In Europe, S. pneumoniae is the most common cause of community-acquired bacterial pneumonia in adults. Still, very little is known about its colonization within this age group. A team of researchers from ITQB NOVA has now taken a crucial step to clarify the dynamics of carriage of this bacterium in adults. This bacterium, also known as pneumococcus, can asymptomatically colonize the human upper respiratory tract. Colonization not only precedes diseases but is also essential for transmission. Even ...

Sculpted by starlight: A meteorite witness to the solar system's birth

Sculpted by starlight: A meteorite witness to the solar systems birth
2021-07-06
In 2011, scientists confirmed a suspicion: There was a split in the local cosmos. Samples of the solar wind brought back to Earth by the Genesis mission definitively determined oxygen isotopes in the sun differ from those found on Earth, the moon and the other planets and satellites in the solar system. Early in the solar system's history, material that would later coalesce into planets had been hit with a hefty dose of ultraviolet light, which can explain this difference. Where did it come from? Two theories emerged: Either the ultraviolet light came from our then-young sun, or it came from a large nearby star in the sun's stellar nursery. Now, researchers from the lab of Ryan Ogliore, assistant professor of physics in Arts ...

Structuring the cerebral neocortex

Structuring the cerebral neocortex
2021-07-06
The neocortex is a layered structure of the brain in which neurons are arranged parallel to each other. This organization is critical for healthy brain function. A team of researchers from Charité - Universitätsmedizin Berlin have uncovered two key processes that direct this organization. Reporting in Science Advances*, the researchers identify one crucial factor which ensures the timely movement of neurons into their destined layer and, subsequently, their final parallel orientation within this space. The neocortex is the outer region of the brain. It is responsible for cognitive functions such as language, decision-making, and ...

Electrokinetic proton transport in triple conducting oxides as key descriptor for highly efficient protonic ceramic fuel cells

Electrokinetic proton transport in triple conducting oxides as key descriptor for highly efficient protonic ceramic fuel cells
2021-07-06
A research team, led by Professor Guntae Kim in the School of Energy and Chemical Engineering at UNIST has introduced an innovative way to quantify proton kinetic properties of triple (H+/O2?/e?) conducting oxides (TCOs) being a significant indicator for characterizing the electrochemical behavior of proton and the mechanism of electrode reactions. Layered perovskites have recently received much attention as they have been regarded as promising cathode materials for protonic ceramic fuel cells (PCFCs) that use proton conducting oxide (PCO) as an electrolyte. Therefore, quantitative characterization of the proton kinetics in TCO can be an important indicator providing a scientific ...

Face off for best ID checkers

2021-07-06
Psychologists from UNSW Sydney have developed a new face identification ability test that will help find facial recognition experts for a variety of police and government agencies, including contract tracing. The Glasgow Face Matching Test 2 [GFMT2] targets high-performing facial recognition individuals known as super-recognisers, who have an extraordinary ability to memorise and recall faces. The type of professional roles that involve face identification and that could benefit from the test include visa processors, passport issuers, border control officers, ...

LAST 30 PRESS RELEASES:

Researchers develop robotic sensory cilia that monitor internal biomarkers to detect and assess airway diseases

Could crowdsourcing hold the key to early wildfire detection?

Reconstruction of historical seasonal influenza patterns and individual lifetime infection histories in humans based on antibody profiles

New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu

Presenting a Janus channel of membranes for complete oil-and-water separation

COVID-19 restrictions altered global dispersal of influenza viruses

Disconnecting hepatic vagus nerve restores balance to liver and brain circadian clocks, reducing overeating in mice

Mechanosensory origins of “wet dog shakes” – a tactic used by many hairy mammals – uncovered in mice

New study links liver-brain communication to daily eating patterns

Defense or growth – How plants allocate resources

Study identifies hip implant materials with the lowest risk of needing revision

Study reveals how plants grow thicker, not just taller

Insect-killing fungi find unexpected harmony in war

Unlocking predictors of success in treating inflammatory bowel disease (IBD)

New PFAS removal process aims to stamp out pollution ahead of semiconductor industry growth

Researchers identify reduction in heart failure-related risk factors following metabolic surgery

The Kenneth H. Cooper Institute at Texas Tech University Health Sciences Center unveiled in Dallas

DNA evidence rewrites story of people buried in Pompeii eruption

DNA evidence rewrites histories for people buried in volcanic eruption in ancient Pompeii

People with schizophrenia show distinct brain activity when faced with conflicting information

Climate change: Significant increase in carbon dioxide emissions from private aviation

Planting trees in the Arctic could make global warming worse, not better, say scientists

Finding function for noncoding RNAs using a new kind of CRISPR

Neurodevelopment in the first 2 years of life following prenatal exposure to maternal SARS-CoV-2 Infection

Racial disparities in genetic detection rates for inherited retinal diseases

Stem cells shed insight into cardiovascular disease processes 

New study: Plastics pollution worsen the impacts of all Planetary Boundaries

Long-term risks from prostate cancer treatment detailed in new report

Does more virtual care mean more low-value care? Study suggests no

City of Hope Research Spotlight, October 2024

[Press-News.org] Doctors warn against off-label use of new Alzheimer's drug for cerebral amyloid angiopathy
There is no clinical evidence that the monoclonal antibody aducanumab is beneficial to patients with cerebral amyloid angiopathy, according to officers with the International Cerebral Amyloid Angiography Association.